Debs et al. “Lung-Specific Delivery . . . ” Journ. Immunology 140: 3482-3488 May 15, 1988.* |
Takada et al., J. Pharm. Dyn. 1:281-287 (1987). “Evidence for the pulmonary absorption of fluorescent labelled macromolecular compounds”. |
Niven et al, Pharmaceutical Research 7:990-994 (1990), Solute Absorption from the Airways of the Isolated Rat Lung. III. Absorption of Several Peptidase-Resistant, Synthetic Polypeptides: Poly-(2-Hydroxyethyl-)Aspartamides. |
Byron et al; Protein Delivery by Aerosol, In: Polymeric drugs and drug delivery systems 1991, pp. 128-138, Opportunities for Protein Delivery by Aerosol— “Absorption and Retention of Several Synthetic Polypeptides in the Lung”. |
Byron et al; J. Bioactive and Combatible Polymers 6:25-35 (1991) “Airway Retentionand Pulmonary Absorption of Poly-a, b-[N(2-hydroxyethyl)-D, L-aspartamide]”. |
Theodore et al; Am J. Physiol. 229:989-996 (1975) “Transalveolar Transport of Large Polar Solutes (sucrose, inulin, and dextran)”. |
Huchon et al; J. Nucl. Med. 28, 894-902 (1987) “Respiratory Clearance of Aerosolized Radioactive Solutes of Varying Molecular Weight”. |
Folkesson et al. Scand. 139: 347-354 (1990) “Permeability of the Respiratory Tract to Different-sized Macromolecules after Intratracheal Instilltion in Young and Adult Rats”. |
Folkesson et al., J. Appl. Physiol. 71:1106-1111 (1991) “Lung to Blood Passage of Different-sized Molecules During Lung Inflammation in the Rat”. |
Jones et al., JPP 40:92P (1988) “Pulmonary Absorption of Aerosolised Insulin in the Rabbit”. |
Jones, et al., JPP 39: 156P (1987) “Insulin Bioavailability After Pulmonary Administration to Volunteers”. |
Huchon et al., Amer. Rev. Resp. Dis. 131: A422 (1985) “Respiratory Epithelial Permeability to Various Molecular Weight Aerosolized Solutes”. |
Scharker et al., Bichem. Pharmacology 32:2599-2601 (1983) “Relation Between Molecular Weight and Pulmonary Absorption Rate of Lipid-insoluble Compounds in Neonatal and Adult Rats”. |
O'Hagen et al., Critical Reviews in Therapeutic Drug Cancer Systems 7:35-97 (1990) at pp. 58-59. |
Francis, Focus on Growth Factors 3: 4-10 (May 1992) (published by Mediscript, Mountainview Court, Friem Barnet Lane, London N20 OLD, UK). |
Malik et al., Exp. Hematol. 20: 1028-1035 (1992) “Polyethylene Glycol (PEG)-modified Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) with Conserved Biological Activity”. |